Functional specialization in a multicellular organism arises when cell fate is established by a specific gene expression pattern. During development from a totipotent cell this is accomplished by the synthesis of spatial and signaling cues that result in epigenetic modifications to elicit unipotent gene expression. Once established, such gene expression patterns are stable unless disrupted by disease or injury. Remarkably the over expression of a few proteins can result in reprogramming of an established cell fate to generate induced pluripotent stem cells (iPSCs) that have the potential to develop into any of the cells of an embryo just like embryonic stem cells (ESCs). iPSCs are the ideal starting point for regenerative therapy since they overcome the ethical and practical concerns of using ESCs. Thus reprogramming provides an ideal model system to mechanistically define cell identity safeguards. However a critical barrier to studying reprogramming is the low efficiency (~3%) and differential kinetics (2-3 weeks) of obtaining iPSCs, so that heterogeneous transcriptional changes are masked in population based studies. We have generated a high efficiency system that combines epigenetic and signaling regulators. Using this system, in this proposal we will determine the most parsimonious route of reprogramming to iPSCs and elucidate the chromatin transitions in cells that become reprogrammed.

Public Health Relevance

The creation of induced pluripotent stem cells (iPSCs) by the process of reprogramming of somatic cells to an embryonic stem cell (ESC)-like state represents a remarkable cell fate change. iPSCs are functionally equivalent to ESCs in the potential to form many other cell types in response to differentiation stimuli, overcome both the practical and ethical limitations of ESCs and have the additional attractive property in that they can be tailor-made for each patient or at least for each HLA-type in a population thus minimizing chances of immune rejection of replacement tissue. In this proposal we will gain a significant understanding of the mechanism of reprogramming which will be highly impactful in translating the use of iPSCs for therapeutic purposes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM113033-06
Application #
9973438
Study Section
Development - 2 Study Section (DEV2)
Program Officer
Gibbs, Kenneth D
Project Start
2015-07-10
Project End
2024-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Zaidan, Nur Zafirah; Walker, Kolin J; Brown, Jaime E et al. (2018) Compartmentalization of HP1 Proteins in Pluripotency Acquisition and Maintenance. Stem Cell Reports 10:627-641
Buxton, Katherine E; Kennedy-Darling, Julia; Shortreed, Michael R et al. (2017) Elucidating Protein-DNA Interactions in Human Alphoid Chromatin via Hybridization Capture and Mass Spectrometry. J Proteome Res 16:3433-3442
Roy, Sushmita; Sridharan, Rupa (2017) Chromatin module inference on cellular trajectories identifies key transition points and poised epigenetic states in diverse developmental processes. Genome Res 27:1250-1262